Skip to content

Clinical trials

Terminated Phase 2 Cholangiocarcinoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cholangiocarcinoma Phase: Phase 2 Status: Terminated Clear all

29 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20092
20111
20131
20143
20154
20171
20181
20192
20202
20216
20222
20231
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated29

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AIO-Studien-gGmbH1
Aiwu Ruth He, MD1
Allina Health System1
American University of Beirut Medical Center1
BIND Therapeutics1
CSPC Ouyi Pharmaceutical Co., Ltd.1
Criterium, Inc.1
Delcath Systems Inc.1
Elevation Oncology1
EpicentRx, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cholangiocarcinoma29
Bile Duct Neoplasms6
Gallbladder Neoplasms5
Carcinoma, Hepatocellular4
Sarcoma4
Biliary Tract Neoplasms3
Colorectal Neoplasms3
Ovarian Neoplasms3
Pancreatic Neoplasms3
Uterine Cervical Neoplasms3

Trials

Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.